Zymewire

FEBRUARY 8, 2024

Over t his period , Axonis has brought together and become world leaders in KCC2 biology , which has further separated us from our competition. To what extent has the prospect of a looming recession influenced your research & development strategy? It was a “Technology in Space” grant put together by the ISS NL , NASA, and Boeing.

Competition 52

Competition Leads Patients Marketing 52

Evolve Your Success

APRIL 11, 2023

We have launched into the US marketplace and got the product design through FDA. My company standpoint is, “Online is the new prospecting tool.” Online is the new prospecting tool. I’ve got an FDA issue.” It’s very competitive. We are launching it here in the US. I embrace it too.

Sales 52

Sales Medical Medical sales Media 52

Pharmaceutical Technology

JUNE 13, 2023

The US Food and Drug Administration (FDA) approved Ferring Pharmaceuticals’ Prior-Approval Supplement (PAS) to the Biologics License Application (BLA) for the bladder cancer gene-therapy Adstiladrin (nadofaragene firadenovec). The company aims to then increase supplies in 2024.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Pharmaceutical 98

Pharmaceutical Technology

FEBRUARY 17, 2023

In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The focus on identifying the ideal drug dosage is not new.

FDA 115

FDA Side effects Pharmacology Patients 115

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Biosimilar uptake could be more gradual.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

APRIL 24, 2023

Covid-19 vaccines from Moderna and Pfizer /BioNTech, which use lipid nanoparticles, became the only two FDA-approved vaccines for almost all ages. However, after a period of slow movement in the field, the FDA approved the first nanodrug, Doxil, for Kaposi sarcoma in 1995. GlobalData is the parent company of Pharmaceutical Technology.

Medicine 59

Medicine Pharmaceutical FDA Sales 59